Vitamin B5 rewires Th17 cell metabolism via impeding PKM2 nuclear translocation
Chen Chen,Weiqiao Zhang,Tingyue Zhou,Qiuyuan Liu,Chao Han,Zonghui Huang,Si Chen,Qiao Mei,Cunjin Zhang,Kaiguang Zhang,Hongdi Ma,Rongbin Zhou,Wei Jiang,Wen Pan,Shu Zhu
DOI: https://doi.org/10.1016/j.celrep.2022.111741
IF: 8.8
2022-11-30
Cell Reports
Abstract:Metabolic rewiring is essential for Th17 cells' functional identity to sense and interpret environmental cues. However, the environmental metabolic checkpoints with specific regulation of Th17 cells, manifesting potential therapeutic opportunities to autoimmune diseases, remain largely unknown. Here, by screening more than one hundred compounds derived from intestinal microbes or diet, we found that vitamin B5 (VB5) restrains Th17 cell differentiation as well as related autoimmune diseases such as experimental autoimmune encephalomyelitis and colitis. Mechanistically, VB5 is catabolized into coenzyme A (CoA) in a pantothenate kinase (PANK)-dependent manner, and in turn, CoA binds to pyruvate kinase isoform 2 (PKM2) to impede its phosphorylation and nuclear translocation, thus inhibiting glycolysis and STAT3 phosphorylation. In humans, reduced serum VB5 levels are found in both IBD and MS patients. Collectively, our study demonstrates a role of VB5 in Th17 cell metabolic reprograming, thus providing a potential therapeutic intervention for Th17 cell-associated autoimmune diseases. Introduction Th17 cells are a CD4 + T helper cell subset, characterized by production of cytokine IL-17A, IL-17F, and granulocyte-macrophage colony-stimulating factor (GM-CSF). 1 Park H. Li Z. Yang X.O. Chang S.H. Nurieva R. Wang Y.H. Wang Y. Hood L. Zhu Z. Tian Q. Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005; 6 : 1133-1141 https://doi.org/10.1038/ni1261 Crossref PubMed Scopus (3413) Google Scholar , 2 Harrington L.E. Hatton R.D. Mangan P.R. Turner H. Murphy T.L. Murphy K.M. Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005; 6 : 1123-1132 https://doi.org/10.1038/ni1254 Crossref PubMed Scopus (3766) Google Scholar , 3 Langrish C.L. Chen Y. Blumenschein W.M. Mattson J. Basham B. Sedgwick J.D. McClanahan T. Kastelein R.A. Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005; 201 : 233-240 https://doi.org/10.1084/jem.20041257 Crossref PubMed Scopus (3215) Google Scholar T cell receptor (TCR) signaling combined with cytokine milieus IL-6, TGF-β1, and IL-23 to direct Th17 cell differentiation by inducing phosphorylation of STAT3 and transcription of RAR-related orphan receptor gamma (RORγt), 4 Ivanov I.I. McKenzie B.S. Zhou L. Tadokoro C.E. Lepelley A. Lafaille J.J. Cua D.J. Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006; 126 : 1121-1133 https://doi. -Abstract Truncated-
cell biology